Prostate cancer is usually diagnosed by physical examination, biochemical markers, prostate-specific antigen (PSA) testing and conventional imaging techniques, such as magnetic resonance imaging (MRI) and computed tomography (CT), which detect morphological changes in the tissue (3). This evidence concerns the gene KLK3 and prostate cancer.